Previous 10 | Next 10 |
4 Psychedelic Stocks For Your Watch List This Year Whether you’ve traded for decades or just opened an account, the market attracts you for a reason. That is usually related to making money & penny stocks have become a clear focus for traders this year. Not only that, but...
The obesity issue is bursting at the seams all over the world. In fact, according to the World Health Organization (WHO) obesity has tripled in size over the last 50 years. In 2016, they note, 1.9 billion adults were overweight around the world. Of those, 650 million were considered obe...
The following slide deck was published by COMPASS Pathways plc in conjunction with this event. For further details see: COMPASS Pathways (CMPS) Investor Presentation - Slideshow
Clinical studies continue to support the use of psilocybin for mental health. For example, a study from JAMA Psychiatry found that psilocybin “worked better than the usual antidepressant medications,” as noted by NPR. New York University. found “Psilocybin produced imme...
Palm Beach, FL – January 12, 2021 – After being relegated to the margins of sincere scientific examination for about five decades, growing researchers and scientists are exploring the therapeutic value of psychedelic drugs and compounds that could be a new treatment option for...
A stunning mental health breakthrough has unleashed a massive opportunity. So much so, it could provide much-needed relief for nearly 700 million people around the world with mental health issues . The incredible thing is, it could all start with a small dose of psychedelics, like psilo...
COMPASS Pathways establishes Centre of Excellence with Sheppard Pratt to accelerate research and improve patient experience in mental health care London, UK – 8 January 2021 COMPASS Pathways plc (Nasdaq: CMPS) (“COMPASS”), a mental health care company de...
COMPASS Pathways establishes Centre of Excellence with Sheppard Pratt to accelerate research and improve patient experience in mental health care London, UK – 8 January 2021 COMPASS Pathways plc (Nasdaq: CMPS) (“COMPASS”), a mental health c...
With a good deal of support from the US FDA, clinical studies, U.S. cities and states, psilocybin could be on the same path taken by cannabis. While psychedelics are still illegal in most states and under federal law, Oregon just became the first state to decriminalize it. Now there’...
Psychedelics are on the cusp of a major boom, and could soon go mainstream. With US FDA support, clinical research studies, and legalization in Oregon, it may only be a matter of time before other states begin to join in. In fact, there are reports California could decriminalize it, too. Ac...
News, Short Squeeze, Breakout and More Instantly...
2024-08-01 23:30:19 ET Image source: The Motley Fool. Compass Pathways Plc (NASDAQ: CMPS) Q2 2024 Earnings Call Aug 01, 2024 , 8:00 a.m. ET Operator Continue reading For further details see: Compass Pathways Plc (CMPS) Q2 2024 Earnings Call Tr...
Top-line COMP005 data for COMP360 phase 3 pivotal program in treatment-resistant depression expected in fourth quarter 2024 Gino Santini to join Board of Directors as Chairman Lori Englebert named new Chief Commercial Officer Cash position of $228.6 million ...
LONDON, July 24, 2024 (GLOBE NEWSWIRE) -- Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that it will release financial results for the second quarter 2024 ending June 30, 2024, a...